Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/atorvastatin single-pill therapy in newly diagnosed hypertension and dyslipidemia
ChiCTR-OPN-15005827Phase 4Completed
- Sponsor
- Peking University Third Hospital Cardiology Department
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amlodipine and atorvastatin in hypertension (HTN) and hyperlipidemia, sponsored by Peking University Third Hospital Cardiology Department. Primary endpoint: Endothelial microparticles. Started Dec 2011; status: completed.
02
Drugs
amlodipineatorvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on ChiCTR-OPN-15005827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15005827.